Sudarshan Anand, Ph.D.

2008 Johns Hopkins University, Baltimore, MD 
Immunology, Cell Biology
"Sudarshan Anand"


Sign in to add mentor
Lieping Chen grad student 2008 Johns Hopkins
 (Light, Lymphotoxin beta receptor and herpes virus entry mediator: Mediators of cell death and proliferation.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Seguin L, Kato S, Franovic A, et al. (2014) An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nature Cell Biology. 16: 457-68
Westenskow PD, Kurihara T, Aguilar E, et al. (2013) Ras pathway inhibition prevents neovascularization by repressing endothelial cell sprouting. The Journal of Clinical Investigation. 123: 4900-8
Anand S. (2013) A brief primer on microRNAs and their roles in angiogenesis. Vascular Cell. 5: 2
Lau SK, Shields DJ, Murphy EA, et al. (2012) EGFR-mediated carcinoma cell metastasis mediated by integrin αvβ5 depends on activation of c-Src and cleavage of MUC1. Plos One. 7: e36753
Park JJ, Anand S, Zhao Y, et al. (2012) Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory. Cancer Immunology, Immunotherapy : Cii. 61: 203-14
Mielgo A, Seguin L, Huang M, et al. (2011) A MEK-independent role for CRAF in mitosis and tumor progression. Nature Medicine. 17: 1641-5
Sakoda Y, Anand S, Zhao Y, et al. (2011) Herpesvirus entry mediator regulates hypoxia-inducible factor-1α and erythropoiesis in mice. The Journal of Clinical Investigation. 121: 4810-9
Anand S, Majeti BK, Acevedo LM, et al. (2010) MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nature Medicine. 16: 909-14
Park JJ, Omiya R, Matsumura Y, et al. (2010) B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance. Blood. 116: 1291-8
Murphy EA, Shields DJ, Stoletov K, et al. (2010) Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF. Proceedings of the National Academy of Sciences of the United States of America. 107: 4299-304
See more...